Elemental analysis and molar conductance
Manganese nitazoxanide complex is stable and insoluble in water. The molar conductance measured was Λm = 18 (Ω
-1 mol
-1 cm
-1), confirming the non-electrolytic behaviour as confirmed previously in a lot of studies (
El-Megharbel et al., 2025;
AlZahrani et al., 2025 and
Al-Thubaiti et al., 2025). Elemental analyses (C, H and N) of nitazoxanide complex [Mn (NITA)
2(cl)
2] confirmed the 1:2 Mn
+2: nitazoxanide ratio.
Infrared spectra
IR data for free nitazoxanide and its Mn (II) metal complex which are shown in (Fig 4). By comparing spectrum of IR for nitazoxanide with its Mn
+2 complex showed that the stretching vibration of NH amide group disappeared upon chelation to Mn (II) complex and shifted to higher frequencies, confirming that the NH amide group is involved in chelation
(Ivana et al., 2010). The stretching vibration for ester group appeared at 1772 cm
-1 and 1160 cm
-1 due to C=O and C-O, respectively.
A shift in C=O carbonyl group value referred to it was involved in the chelation process. The binding effect to the ester oxygen caused the band, which first emerged in nitazoxanide at 1160 cm
-1, to move to a lower frequency with low intensity. The nitazoxanide molecule underwent chelation at these primary sites, undergoes blue shift for C=O amide and C=N modes of vibration in the thiazole ring following chelated to the Mn (II) ion.
For IR for the manganese complex there are new bands appeared at 699 cm
-1 and 530 cm
-1 range, which are referred to v(M-O) and a new band appeared at 490 cm
-1, referred to v(M-N) (
Nakamoto, 1970;
Bellamy, 1975).
UV-Vis spectra and magnetic measurements
Table 1 show the uv-vis spectra for free NITA and its Mn complex. For nitazoxanide two absorption maxima appeared at 225 and 410 nm. The band appearing at 410 nm is due to π → π* transitions, while for 225 nm is attributed to n → π* transitions. Weak bands at 280 and 240 nm for Manganese (II) complex, due to to π → π* and n → π* transitions. The octahedral planner shape of the [Mn (NITA)
2(H
2O)
2Cl
2] complex was validated by the magnetic moment of 5.236 BM for the Mn (II) complex (
Cotton et al., 1962;
Figgis, 1967).
SEM and TEM investigations
SEM image for NITA and its [Mn (NITA)
2(H
2O)
2Cl
2] complex Fig 5. A tiny particle size with nano feature products. Using SEM analysis, the surface morphology of NITA and its Mn
+2 complex was detected. All particles were shown to have a high capacity to form agglomerates with variety of shapes. TEM images for NITA and its Mn
+2 complex Fig 5 shows a homogenous phase material that confirms the ordered arrangement for NITA metal chelate matrix and its Mn
+2 complex. A spherical black spot is appeared within nano-range particle sizes.
Molecular docking of NITA/Mn complex with sigma receptor
Sigma receptors are essentially expressed intracellularly in the nervous system, especially the glial cells and mainly regulate the functions of the ion channels. Additionally, sigma receptors mainly reside in (ER) “Endoplasmic Reticulum” and act as pharmacochaperones to modulate neurotransmission
via different receptors and transporters. Thus, sigma receptors are thought to be involved in the effects of many drugs
(Liechti et al., 2022).
Thus, Sigma α-1 receptors are unique, chaperone proteins located primarily in the endoplasmic reticulum (ER) membrane. They act as ligand-regulated molecular chaperones that modulate ion channels, calcium signaling and neurotransmitter systems, playing crucial roles in neuroprotection, cell survival and psychiatric disorders. Sigma receptors act as intracellular chaperones, often regulating ER stress and calcium flow at the mitochondria-associated ER membrane (MAM). They are highly expressed in the central nervous system and other tissues. While sigma receptor originally thought to be opioid receptors, but the current metal complex NITA/Mn recently chelates with the sigma receptor via recording binding affinity with Med activity and the NITA/Mn complex showed a binding interaction energy ranging from -6.8 to -7.2 kcal/mol for sigma receptor with mean (-6.97) (Table 2) and (Fig 6) which is Med which is a novel result that may open the gate for more prospective studies.
DFT analysis
HOMO-LUMO energy gap calculation and global descriptors
The frontier molecular orbital (FMO) analysis revealed distinct differences in the electronic properties of Mn-NITA complex. Mn-NITA exhibited a HOMO energy of -11.589 eV and a LUMO energy of -5.708 eV, resulting in a relatively large energy gap (ΔE) of 5.881 eV. The larger ΔE value of Mn-NITA indicates greater kinetic stability and lower chemical reactivity. The ionization potential (IP) and electron affinity (EA) further support this trend, with Mn-NITA demonstrating higher IP (11.589 eV), suggesting that Mn-NITA is less prone to electron donation.
The calculated global reactivity descriptors reinforce these observations. Mn-NITA exhibited higher chemical hardness (η = 2.941 eV). Additionally, Mn-NITA (12.72 eV), suggesting a stronger tendency to accept electrons. The chemical potential (μ) and electronegativity (χ) values also reveal that Mn-NITA possesses greater overall electronic stability. Overall, these results suggest that Mn-NITA is comparatively more stable and less reactive, which may influence its interaction behavior in chemical or biological systems, as shown in Table 3 and Fig 7.
IR plot
The IR spectra further confirm the vibrational characteristics of the complex. Strong absorption bands were observed in the 400-1800 cm
-1 region, with maximum molar absorptivity (ε) values reaching approximately 1100-1200 M
-1 cm
-1 for Mn-NITA. Prominent peaks near ~1600-1700 cm
-1 correspond to azomethine (C=N) stretching vibrations, while bands in the 1000-1300 cm
-1 region are associated with C-N and C-O stretching modes. The low-frequency region below 600 cm
-1 exhibits bands attributed to metal-ligand (M-N and M-Cl) vibrations, confirming successful coordination. Additionally, broad features around ~3400-3550 cm
-1 indicate O-H stretching vibrations. Notably, Mn-NITA demonstrates a slightly enhanced dipole strength (~1.8 × 10-40 esu²·cm²), suggesting stronger IR-active transitions in the Mn complex (Fig 8).
Raman activity
The Raman activity spectra of the Mn-NITA complex display prominent vibrational features across the 0-4000 cm
-1 region. For Mn-NITA complex, intense high-frequency bands were observed in the 3200-3550 cm
-1 range, corresponding to O-H and N-H stretching vibrations, with maximum intensities approaching ~10-12 arbitrary units and scattering activities nearing ~250 Εt /amu. In the fingerprint region (1000-1800 cm
-1), distinct strong peaks were recorded around ~1550-1700 cm
-1, attributable to C=N and C=S stretching modes. Mn-NITA exhibited comparatively sharper and slightly higher intensity peaks in this region, suggesting stronger metal-ligand coupling. Overall, Mn-NITA complex demonstrates significant Raman activity, with the high-frequency stretching region being the most dominant, as shown in Fig 9.
Potential energy surface (PES) analysis
The three-dimensional potential energy surface (PES) plots reveal the stability landscape of the Mn-NITA complex along the scanned coordinates (SC1). For Mn-NITA, the total energy varies within a narrow range of approximately -438.32 to -438.26 Hartree, showing multiple local minima and maxima, indicative of a rugged energy surface with several accessible conformational states. The deeper minima observed for Mn-NITA suggest greater thermodynamic stability. These findings correlate well with the previously calculated global reactivity descriptors, reinforcing that Mn-NITA is energetically more stable, as shown in Fig 10.
Antioxidant capacities of NITA and it’s Mn metal complex
The estimated percentages obtained of the chelating activity of NITA/Mn via using different assays of scavenging free radicals which are shown in Table 4. The assay of ABTS, Metal chelation and the assay of DPPH were used. The capacity of the NITA and NITA/Mn complex to scavenge the free radicals of ABTS was 230.51, which is more than NITA itself. Meanwhile, the metal chelating activity of NITA/Mn was higher than NITA itself by 72.41% (µM EDTA eq/mg), respectively.
Meanwhile, the scavenging ability of NITA/Mn was also the highest stable via the DPPH radical activity by 26.80 (µM trolox eq/mg). But, the metal complex (NITA/Mn) has a greater chelating capacity by 60.92 (µM trolox eq/mg) than NITA itself (Table 4).
NITA is a commonly used treatment for many types of intestinal protozoa. However, its low solubility is a real barrier for high treatment percentages in many protozoan infections. Thus, there is an urgent need for the development of new drugs to benefit from their tremendous advantages
(Hagras et al., 2025; Hagras et al., 2023).
An innovative scientific trend in the drug delivery models is represented via the new formulation of metal drug complexes in order to overcome a lot of limitations regarding the commercial drugs
(Hagras et al., 2019; Allam et al., 2022).
NPs with a very small size range have high potency to penetrate across the tissues. Consequently, this would increase the permeability of the new drug formulations and decrease the dose of the synthesized drugs. Additionally, these synthesized formulae offer a cost-effective strategy as the nano-encapsulation vehicles’ development is almost cheaper
(Hagras et al., 2023).
Consequently, the excessive production of the oxidative injury markers due to a lot of parasitic infections is considered as areal and major reason for the incidence of tissue damage
(Yan et al., 2015). Eventually, the oxidative injury markers of MDA were previously studied (
Albogami, 2024 and
Albogami, 2025). This oxidative injury is evidenced by the highest MDA levels in the parasitically infected groups. This observation reinforced the novel findings of the current study, which confirmed the antioxidant capacities of the novel complex NITA/Mn over the NITA drug only via
in vitro antioxidant assays ABTS, DPPH and metal chelation.
Interestingly, the current findings are in great accordance with the study of
Hagras et al., (2025), who proved that treated groups with NITA-loaded ZnO exhibited a reduction in the estimated oxidative biomarkers, which greatly confirmed the novel concept of the current study
via the effectiveness of the novel synthesized complex NITA/MN
via the high
in vitro antioxidant capacities. These findings are essentially consistent with
(Ashour et al., 2016; Nagajyothi et al., 2015) previous studies, which focused on NITA loaded with ZnO NPs effects in mitigating and declining the oxidative injury due to the parasitic infections.
This surprising decline in the oxidative markers after treatment with NITA new formulations further reinforces the therapeutic benefits of the novel metal complex formula in alleviating the oxidative injury markers associated with parasitic infections, which is in accordance with the previous potent effects of NITA as reported by
(Hemphill et al., 2006).
The main aim of the current study was to synthesize a nano-sized novel formula of NITA/Mn to enhance its biological actions via measurement of the antioxidant capacities
in vitro and DFT analysis of the utilized novel drug, which confirmed its high energy stability. The nano-formula was synthesized and characterized based in my knowledge for the 1
st time as a potent antioxidant via
in vitro antioxidant assay. The results of the NITA/Mn characterization denoted that it lies in the nano-sized range. This smaller particle’s size saves high surface area as compared to the volume and eventually leads to higher penetration across the cellular membranes
(Melk et al., 2021).
FTIR spectroscopy exhibited peaks that are attributed to (MnO stretching) the metal-oxygen vibration mode, while the clear shift that appeared in the FT-IR peaks indicates a high success of NITA/Mn as previously confirmed
(Sawant et al., 2018).
Simulation docking with sigma receptor and DFT analysis revealed that NITA/Mn metal complex exhibited a Med docking force with Med energy stability. This is usually preferable as it offers a sufficient drug amount across the body tissues (
El-Wakil et al., 2023).
There is an emerging indirect relationship between sigma receptors (particularly the sigma-1α receptor) and parasitic infections and inflammatory pathways, rather than direct binding to the parasite itself. Recently, sigma-1 receptors act as intracellular chaperones, managing endoplasmic reticulum stress and modulating neuroinflammation, which is crucial during parasitic invasions. This is in agreement with the current concept regarding a NITA-based Mn (II) compound with its activity in docking with this receptor and concurrently its potent antioxidant activities.
The mechanism of action of NITA is represented by inhibiting the pyruvate ferredoxin oxido-reductase enzyme, which can alter the parasitic metabolism, especially the respiratory system, besides causing a lot of cellular membrane lesions
(Hagras et al., 2023). Despite the safe NITA nature in general, it still has decreased efficacy due mainly to its poor solubility as previously mentioned. Even NITA/Mn revealed the highest significant drug stability, which offered Med benefits via improving the drug solubility that can effectively enhance in prospective
in vivo studies, the drug permeability and the efficacy.